Discover the newest research about AI innovations in π€ Personalized Medicine.
Machine learning predicts cancer symptoms effectively, with AUROCs from 0.66 to 0.73 across 82 centers. ππ€
AI enhances T-cell immunotherapy and vaccine development, improving predictions of T cell responses. π€π
AI transforms cardiovascular health post-COVID, enhancing risk prediction and real-time monitoring. Key for public health strategies! π«π
New deep learning tool, Flexynesis, improves cancer treatment precision by analyzing multi-omics data and medical images. π§¬π»
AI and Oral Microbiome: Transforming Early Detection of Oral Cancer π¦·π€
Machine learning predicts cancer patient mortality dynamics, revealing three clinical patterns and key lab parameters. ππ‘
New AI tools from Penn enhance kidney disease treatment by analyzing cellular data for personalized therapies. π§¬π
Plasma proteomics reveals four sepsis subtypes, with Cluster 0 showing 100% mortality. Key for personalized therapies! β οΈπ¬
Exploring biomarkers in high-risk prostate cancer: 50-75% relapse rate post-treatment. Genomic profiling enhances precision oncology. ππ¬
AI-driven reverse docking revolutionizes drug discovery, enhancing target identification and repurposing. Key insights from PubMed review. ππ€
